Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04592653 |
|---|---|
| Brief Title: | Less Frequent IV Dosing & Tumor Microenvironment (TME) Study of Nemvaleukin Alfa (ALKS 4230) Monotherapy and in Combination With Pembrolizumab (ARTISTRY-3) (ARTISTRY-3) |
| First Submitted : | August 24, 2020 |
| First Submitted that Met QC Criteria : | October 12, 2020 |
| First Posted : | October 19, 2020 |
| Last Update Submitted that Met QC Criteria : | January 23, 2024 |
| Last Update Posted : | January 24, 2024 |